These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 38221682)

  • 1. Progress and Challenges in Tumor Ferroptosis Treatment Strategies: A Comprehensive Review of Metal Complexes and Nanomedicine.
    Su Y; Liu B; Wang B; Chan L; Xiong C; Lu L; Zhang X; Zhan M; He W
    Small; 2024 Jun; 20(25):e2310342. PubMed ID: 38221682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Progress in Ferroptosis Inducers for Cancer Therapy.
    Liang C; Zhang X; Yang M; Dong X
    Adv Mater; 2019 Dec; 31(51):e1904197. PubMed ID: 31595562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology Utilizing Ferroptosis Inducers in Cancer Treatment.
    Farzipour S; Zefrei FJ; Bahadorikhalili S; Alvandi M; Salari A; Shaghaghi Z
    Anticancer Agents Med Chem; 2024; 24(8):571-589. PubMed ID: 38275050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress on nanomedicine-induced ferroptosis for cancer therapy.
    Zafar H; Raza F; Ma S; Wei Y; Zhang J; Shen Q
    Biomater Sci; 2021 Aug; 9(15):5092-5115. PubMed ID: 34160488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis Nanomedicine: Clinical Challenges and Opportunities for Modulating Tumor Metabolic and Immunological Landscape.
    Yang H; Yao X; Liu Y; Shen X; Li M; Luo Z
    ACS Nano; 2023 Aug; 17(16):15328-15353. PubMed ID: 37573530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Progress in Ferroptosis Induced Tumor Cell Death by Anti-tumor Metallic complexes.
    Zhou YC; Zhao TK; Tao SM; Wang P; Guan YC; Yang KP; Chen SQ; Pu XY
    Chem Asian J; 2024 Feb; 19(3):e202301020. PubMed ID: 38149729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A promising new approach to cancer therapy: Manipulate ferroptosis by hijacking endogenous iron.
    Zhu L; Du Y
    Int J Pharm; 2024 Sep; 662():124517. PubMed ID: 39084581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanomedicine-mediated ferroptosis targeting strategies for synergistic cancer therapy.
    Yin W; Chang J; Sun J; Zhang T; Zhao Y; Li Y; Dong H
    J Mater Chem B; 2023 Feb; 11(6):1171-1190. PubMed ID: 36650960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasmall Zwitterionic Polypeptide-Coordinated Nanohybrids for Highly Efficient Cancer Photothermal Ferrotherapy.
    Du C; Zhou L; Qian J; He M; Zhang ZG; Feng C; Zhang Y; Zhang R; Dong CM
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):44002-44012. PubMed ID: 34494817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis in cancer therapeutics: a materials chemistry perspective.
    Guan Q; Zhou LL; Dong YB
    J Mater Chem B; 2021 Nov; 9(43):8906-8936. PubMed ID: 34505861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential application of nanomaterials for ferroptosis-based cancer therapy.
    Li Y; Wei X; Tao F; Deng C; Lv C; Chen C; Cheng Y
    Biomed Mater; 2021 Jun; 16(4):. PubMed ID: 34038885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inorganic Nanomedicine-Mediated Ferroptosis: A Synergistic Approach to Combined Cancer Therapies and Immunotherapy.
    Mohapatra A; Mohanty A; Park IK
    Cancers (Basel); 2024 Sep; 16(18):. PubMed ID: 39335181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ferroptosis and cuproptosis: Metal-dependent cell death pathways activated in response to classical chemotherapy - Significance for cancer treatment?
    Kciuk M; Gielecińska A; Kałuzińska-Kołat Ż; Yahya EB; Kontek R
    Biochim Biophys Acta Rev Cancer; 2024 Jul; 1879(4):189124. PubMed ID: 38801962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron based nanotherapeutics for ferroptosis-induced cancer therapy.
    Liu YM; Chen YH; Jin YC; Tang KZ
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11323-11333. PubMed ID: 33215452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between ferroptosis and cuproptosis: From mechanism to potential clinical application.
    Liu N; Chen M
    Biomed Pharmacother; 2024 Feb; 171():116115. PubMed ID: 38181713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advance on combination therapy strategies based on biomedical nanotechnology induced ferroptosis for cancer therapeutics.
    Chen S; Shi J; Yu D; Dong S
    Biomed Pharmacother; 2024 Jul; 176():116904. PubMed ID: 38878686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Ferroptosis to Iron Out Cancer.
    Hassannia B; Vandenabeele P; Vanden Berghe T
    Cancer Cell; 2019 Jun; 35(6):830-849. PubMed ID: 31105042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent research progress based on ferroptosis-related signaling pathways and the tumor microenvironment on it effects.
    Yu S; Tong L; Shen J; Li C; Hu Y; Feng K; Shao J
    Eur J Med Chem; 2024 Apr; 269():116290. PubMed ID: 38518522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research.
    Tong X; Tang R; Xiao M; Xu J; Wang W; Zhang B; Liu J; Yu X; Shi S
    J Hematol Oncol; 2022 Dec; 15(1):174. PubMed ID: 36482419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic nanoparticles for ferroptosis cancer therapy with diagnostic imaging.
    Ko MJ; Min S; Hong H; Yoo W; Joo J; Zhang YS; Kang H; Kim DH
    Bioact Mater; 2024 Feb; 32():66-97. PubMed ID: 37822917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.